Mechanisms Underlying the Protective Vascular Effects of Dietary Potassium in Humans
Launched by UNIVERSITY OF DELAWARE · Sep 23, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how dietary potassium affects blood vessels, especially when people eat a lot of sodium (like in many American diets). Researchers want to understand if increasing potassium intake can help protect the blood vessels in healthy adults who do not typically have high blood pressure. They are looking for participants who are between 65 to 74 years old and are generally healthy, with normal blood pressure and a normal heart rhythm.
To join the study, you must not have high blood pressure, heart disease, diabetes, kidney disease, or be obese. Additionally, you shouldn't have made significant weight changes recently, use tobacco, be pregnant, follow a special diet, or be taking medications for any of these conditions. If you participate, you can expect to contribute to important research that may help in understanding how diet can impact cardiovascular health. This trial is currently recruiting participants, so if you meet the criteria and are interested, it could be a great opportunity to help advance our knowledge in this area.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • healthy
- • normal blood pressure
- • normal resting ECG
- Exclusion Criteria:
- • hypertension
- • history of heart disease
- • diabetes
- • kidney disease
- • obese (BMI ≥30)
- • significant weight changes in the last 6 months
- • use of tobacco products
- • pregnant
- • on a special diet (gluten free; vegan)
- • take any medications for the above conditions
- • endurance trained athletes
About University Of Delaware
The University of Delaware, a renowned research institution, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in various fields, including health sciences, engineering, and behavioral health, to conduct rigorous and ethical research. The university's commitment to scientific excellence and community engagement ensures that its clinical trials not only contribute to groundbreaking discoveries but also prioritize participant safety and well-being. Through its state-of-the-art facilities and a team of experienced researchers, the University of Delaware is positioned to make significant contributions to the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newark, Delaware, United States
Patients applied
Trial Officials
Shannon L Lennon, PhD
Principal Investigator
University of Delaware
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials